The European environmentally related tax revenue from all environmental taxes in manufacturing of basic pharmaceutical products and pharmaceutical preparations witnessed notable variations across countries in 2023. France generated the highest revenue, while countries like Iceland and Estonia recorded minimal collections. Countries such as Norway and Netherlands saw positive growth, whereas countries like Belgium, Sweden, and the Czech Republic faced declines. The five-year CAGR indicates modest growth for many countries, signaling consistent measures to integrate environmental policies into their pharmaceutical sectors.
Looking ahead, key trends to monitor include:
- Implementation of stricter environmental regulations, which could drive tax revenues upward.
- Technological advancements in manufacturing processes that decrease environmental impact, potentially affecting tax structures.
- Evolving environmental policies across Europe, influencing future revenue patterns in the pharmaceutical sector.
Top countries in Environmentally Related Tax Revenue from All Environmental Taxes in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 118.23 | 2023 | +3.89% | +2% | View data |
| 2 | 2 Switzerland | 41.74 | 2023 | +2.92% | +2.07% | View data |
| 3 | 3 Serbia | 24.04 | 2023 | +2.49% | -0.54% | View data |
| 4 | 4 Netherlands | 23.76 | 2023 | +1.43% | +3.42% | View data |
| 5 | 5 Belgium | 21.84 | 2023 | -5.13% | -4.84% | View data |
| 6 | 6 Spain | 20.9 | 2023 | +0.24% | -0.77% | View data |
| 7 | 7 Austria | 16.45 | 2023 | +2.84% | +0.8% | View data |
| 8 | 8 Ireland | 9.77 | 2023 | +9.52% | -2.38% | View data |
| 9 | 9 Sweden | 2.17 | 2023 | -3.32% | -3.31% | View data |
| 10 | 10 Norway | 1.67 | 2023 | +1.88% | +6.31% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
